Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond the clinical eye: mapping intestinal parasitic infections and its risk factors among dogs and cats across Portugal.

Frontiers in veterinary science·2026
Same author

Integrating multi-organ cytokine responses with CTD and AOP-based knowledge to identify disease-relevant hazard signals: A case study of CMIT/MIT.

Toxicology in vitro : an international journal published in association with BIBRA·2026
Same author

Intranasal administration of a DNA vaccine complexed with sugar-functionalized chitosan induces protective immunity against SARS-CoV-2 in mice.

International journal of pharmaceutics·2026
Same author

Patterning bacterial nanocellulose at cell-size scale using UV laser technology to create immunomodulatory interfaces.

Biomaterials advances·2026
Same author

Unraveling the Potential of <i>Giardia</i> Extracellular Vesicles as a Vaccine Candidate.

Pharmaceutics·2026
Same author

Dual functionalization of chitosan/DNA complexes with mannose and hydroxyl-rich acids for enhanced gene delivery efficiency.

International journal of biological macromolecules·2026

Related Experiment Video

Updated: Jun 6, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

Progress towards a needle-free hepatitis B vaccine.

Filipa Lebre1, Gerrit Borchard, Maria Conceição Pedroso de Lima

  • 1Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.

Pharmaceutical Research
|November 20, 2010
PubMed
Summary

Developing new Hepatitis B vaccines is crucial. Needle-free immunization and adjuvants offer a promising approach for safer, more effective Hepatitis B virus (HBV) vaccination strategies.

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

Related Experiment Videos

Last Updated: Jun 6, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

Area of Science:

  • Immunology
  • Vaccinology
  • Public Health

Background:

  • Hepatitis B virus (HBV) infection remains a significant global health concern.
  • Current HBV vaccines are effective, but new generations are needed for improved efficacy and broader application.
  • Needle-free immunization presents an attractive alternative for mass vaccination due to safety, patient compliance, and immune response benefits.

Purpose of the Study:

  • To review adjuvants that enhance needle-free vaccine development against HBV.
  • To explore strategies for creating improved, safer, and more effective HBV vaccines.
  • To highlight the potential of needle-free delivery for both prophylactic and therapeutic HBV vaccination.

Main Methods:

  • Review of scientific literature on adjuvants used in HBV vaccine research.
  • Analysis of studies investigating needle-free immunization techniques for HBV.
  • Evaluation of immunological responses induced by adjuvanted, needle-free HBV vaccine candidates.

Main Results:

  • Adjuvants have been instrumental in enhancing the immunogenicity of experimental HBV vaccines.
  • Needle-free delivery systems, when combined with appropriate adjuvants, can elicit robust systemic and mucosal immune responses.
  • The use of adjuvants is key to optimizing the efficacy of needle-free HBV vaccines.

Conclusions:

  • Adjuvants are essential components for developing next-generation, needle-free Hepatitis B vaccines.
  • Needle-free immunization strategies hold significant promise for global HBV prevention and treatment.
  • Further research into adjuvant selection and formulation is critical for advancing needle-free HBV vaccine technology.